Publications
- Humoral and cellular immune responses to mRNA COVID-19 vaccines in patients with axial spondyloarthritis treated with adalimumab or secukinumab2022 | Second Faculty of Medicine
- SARS-CoV-2-specific humoral and cellular immune responses to BNT162b2 vaccine in Fibrodysplasia ossificans progressiva patients2022 | Second Faculty of Medicine
- Oncostatin M and Nivolumab Affect the Cytotoxic T-Cell Proportions and the Susceptibility to TRAIL-Induced Death in Non-Leukocyte Cell Subpopulations in Soft Tissue Sarcomas2023 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Physical Education and Sport
- A novel anti-CD47-targeted blockade promotes immune activation in human soft tissue sarcoma but does not potentiate anti-PD-1 blockade2023 | Second Faculty of Medicine, First Faculty of Medicine
- Clinical outcomes, immunogenicity, and safety of BNT162b22 Vaccine in Primary Antibody Deficiency2023 | Second Faculty of Medicine
- Clinical Outcome of Coronavirus Disease 2019 in Patients with Primary Antibody Deficiencies2023 | Second Faculty of Medicine
- Encapsulation: A Strategy to Deliver Therapeutics and Bioactive Compounds?2023 | Second Faculty of Medicine
- Gastrointestinal Involvement in Primary Antibody Deficiencies2023 | Second Faculty of Medicine
- Content and specificity of the Anti-SARS-CoV-2 antibodies in solutions for immunoglobulin replacement therapy2023 | Second Faculty of Medicine
- Risk Factors for Severe COVID-19 and Hospital Admission in Patients With Inborn Errors of Immunity - Results From a Multicenter Nationwide Study2022 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové
Loading network view...